Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

The swiss transplant cohort study: lessons from the first 6 years.

Berger C, Bochud PY, Boggian K, Cusini A, Egli A, Garzoni C, Hirsch HH, Hoffmann M, Khanna N, Manuel O, Meylan P, Nadal D, van Delden C, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study.

Curr Infect Dis Rep. 2015 Jun;17(6):486. doi: 10.1007/s11908-015-0486-5.

PMID:
25916997
2.

IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.

Wójtowicz A, Gresnigt MS, Lecompte T, Bibert S, Manuel O, Joosten LA, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch HH, Weisser M, Mueller NJ, Meylan PR, Steiger J, Kutalik Z, Pascual M, van Delden C, van de Veerdonk FL, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study STCS.

J Infect Dis. 2015 May 15;211(10):1646-57. doi: 10.1093/infdis/jiu636. Epub 2014 Nov 14.

PMID:
25398456
3.

Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation.

Manuel O, Wójtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C, Binet I, Weisser M, Berger C, Cusini A, Meylan P, Pascual M, Bochud PY; Swiss Transplant Cohort Study.

J Infect Dis. 2015 Mar 15;211(6):906-14. doi: 10.1093/infdis/jiu557. Epub 2014 Oct 9.

PMID:
25301956
4.

In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study.

Garzoni C, Uçkay I, Belaieff W, Breilh D, Suvà D, Huggler E, Lew D, Hoffmeyer P, Bernard L.

Springerplus. 2014 Jun 7;3:287. doi: 10.1186/2193-1801-3-287. eCollection 2014.

5.

KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.

Gonzalez A, Schmitter K, Hirsch HH, Garzoni C, van Delden C, Boggian K, Mueller NJ, Berger C, Villard J, Manuel O, Meylan P, Stern M, Hess C; Swiss Transplant Cohort Study.

Genes Immun. 2014 Oct;15(7):495-9. doi: 10.1038/gene.2014.39. Epub 2014 Jul 10.

PMID:
25008861
6.

Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.

Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Grossi P; ESCMID Study Group of Infection in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:10-8. doi: 10.1111/1469-0691.12557.

PMID:
24476053
7.

Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study.

Bucheli E, Kralidis G, Boggian K, Cusini A, Garzoni C, Manuel O, Meylan PR, Mueller NJ, Khanna N, van Delden C, Berger C, Koller MT, Weisser M; Swiss Transplant Cohort Study.

Transpl Infect Dis. 2014 Feb;16(1):26-36. doi: 10.1111/tid.12168. Epub 2013 Dec 16.

PMID:
24330137
8.

Microbial communities in the respiratory tract of patients with interstitial lung disease.

Garzoni C, Brugger SD, Qi W, Wasmer S, Cusini A, Dumont P, Gorgievski-Hrisoho M, Mühlemann K, von Garnier C, Hilty M.

Thorax. 2013 Dec;68(12):1150-6. doi: 10.1136/thoraxjnl-2012-202917. Epub 2013 Aug 14.

9.

Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.

Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, Berger C, Boggian K, Cusini A, Koller MT, Weisser M, Pascual M, Meylan PR; Swiss Transplant Cohort Study.

Am J Transplant. 2013 Sep;13(9):2402-10. doi: 10.1111/ajt.12388. Epub 2013 Aug 5.

10.

Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation.

Garzoni C, Vergidis P; AST Infectious Diseases Community of Practice.

Am J Transplant. 2013 Mar;13 Suppl 4:50-8. doi: 10.1111/ajt.12098. No abstract available.

11.

Relevance of cohort studies for the study of transplant infectious diseases.

Berger C, Boggian K, Cusini A, van Delden C, Garzoni C, Hirsch HH, Khanna N, Koller M, Manuel O, Meylan P, Nadal D, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study.

Curr Opin Organ Transplant. 2012 Dec;17(6):581-5. doi: 10.1097/MOT.0b013e328359263a. Review.

PMID:
23111643
12.

Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis.

Zürcher S, Mooser C, Lüthi AU, Mühlemann K, Barbani MT, Mohacsi P, Garzoni C, Gorgievski-Hrisoho M, Schaller A, Flatz L.

J Clin Virol. 2012 Aug;54(4):359-63. doi: 10.1016/j.jcv.2012.04.019. Epub 2012 May 24.

PMID:
22633201
13.

Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients.

Engler K, Mühlemann K, Garzoni C, Pfahler H, Geiser T, von Garnier C.

Swiss Med Wkly. 2012 Jan 30;142:w13509. doi: 10.4414/smw.2012.13509.

14.

[Infections in solid organ transplantation - prophylaxis, diagnostic approach and therapy].

Garzoni C, Müller NJ.

Ther Umsch. 2011 Dec;68(12):735-43. doi: 10.1024/0040-5930/a000238. Review. German.

PMID:
22139990
15.

Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation.

Garzoni C, Ison MG.

Transplantation. 2011 Dec 27;92(12):1297-300. doi: 10.1097/TP.0b013e318236cd02.

PMID:
21996654
16.

Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.

Mühlethaler K, Bögli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Mühlemann K, Garzoni C.

Eur Respir J. 2012 Apr;39(4):971-8. doi: 10.1183/09031936.00095811. Epub 2011 Sep 15.

17.

Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10.

Babouee B, Widmer AF, Dubuis O, Ciardo D, Droz S, Betsch BY, Garzoni C, Führer U, Battegay M, Frei R, Goldenberger D.

Euro Surveill. 2011 Mar 17;16(11). pii: 19817.

18.

Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus.

Garzoni C, Kelley WL.

EMBO Mol Med. 2011 Mar;3(3):115-7. doi: 10.1002/emmm.201100123. Epub 2011 Feb 25. Review. No abstract available.

19.

Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.

Scherrer AU, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Garzoni C, Hirschel B, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF; Swiss HIV Cohort Study (SHCS).

J Acquir Immune Defic Syndr. 2011 May 1;57(1):24-31. doi: 10.1097/QAI.0b013e318211925e.

PMID:
21283013
20.

Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections.

Uçkay I, Garzoni C, Ferry T, Harbarth S, Stern R, Assal M, Hoffmeyer P, Lew D, Bernard L.

Swiss Med Wkly. 2010 Nov 19;140:w13124. doi: 10.4414/smw.2010.13124.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk